HIV-1 therapeutic vaccine (AriaVax)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameHIV-1 therapeutic vaccine (AriaVax)

Drug Alias NameHIV-1 gp120 protein inhibitor (AriaVax)

ClassificationBiologics > Protein drugs > Recombinant polypeptideVaccines > Application > Therapeutic vaccine

Mechanisms of ActionHIV envelope protein gp120 inhibitors

TargetsHIV envelope protein gp120

Therapy Area/IndicationsHIV Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAriaVax Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesAriaVax Inc

Active IndicationsN/A

Inactive IndicationsHIV Infections

ATC CodeN/A